The Effect of Sacubitril-Valsartan on RV functio

Phase 3

Recruiting

• Conditions: I42.0; Condition 1: Ischemic cardiomyopathy. Condition 2: Dilated cardiomyopathy.; Ischemic cardiomyopathy; Dilated cardiomyopathy; I25.5

• Registration Number: IRCT20230926059524N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

patients who aged over 18 years old
patients with any degree of right ventricular failure
written and informed consent

Exclusion Criteria

glomerular filteration rate less than 30 mg/dl
systolic blood pressure less than 100 mmHg
history of angioedema
right heart failure due to acute pulmonary emboli
creatinine more than 2.5mg/dl
renal artery stenosis
hisory of intolerance to the mentioned drugs
Death
Lack of consent to prticipate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Degree of RV dysfunction. Timepoint: At the beginning of the trial, 3 months after using the drug. Method of measurement: Echocardiography.